Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Vidasym's phosphate binder VS-505 enters phase I/II trial

July 23, 2015

Gilead patents MAP3K5 inhibitors

July 20, 2015

ErepoXen increases hemoglobin levels to therapeutic range in phase II trial

July 16, 2015

Merck & Co. divulges ROMK channel blockers

July 15, 2015

Aquinox Pharmaceuticals reports data from LEADERSHIP trial

June 26, 2015

Eppin Pharma receives NIH grant to develop non-hormonal male contraceptive

June 19, 2015

Angion Biomedica to begin phase II trial of BB3 in acute kidney injury

June 10, 2015

Regulus Therapeutics starts phase I trial of Alport syndrome candidate RG-012

June 5, 2015

Galenica to commercialize Roche's Mircera in U.S.

May 29, 2015

Jinarc approved in Europe for autosomal dominant polycystic kidney disease

May 28, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...